Evaluation of the Incremental Healthcare Economic Burden of Atrial Fibrillation Patients Treated with Direct-acting Oral Anticoagulants and Hospitalized for Major Bleeds in the U.S.
posted on 2020-07-20, 15:50authored bySteven B. Deitelzweig, Belinda Lovelace, Mary Christoph, Melissa Lingohr-Smith, Jay Lin, Gregory J. Fermann
The above summary slide represents
the opinions of the authors. For a full list of declarations, including funding
and author disclosure statements, please see the full text online (see “read
the peer-reviewed publication” opposite).